Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

15 results
Display

Myelomatous effusion with poor response to chemotherapy

Kim YM, Lee KK, Oh HS, Park SK, Won JH, Hong DS, Park HS, Park JS, Lee DW

While pleural effusion in multiple myeloma is relatively infrequent, myelomatous pleural effusion is extremely rare. We experienced a 61-year-old woman with IgD-lambda multiple myeloma and pleural effusion. The diagnosis was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Application of vincristine-loaded platelet therapy in three dogs with refractory immune-mediated thrombocytopenia

Park HJ, Kim JW, Song KH, Seo KW

Three dogs presented with refractory immune-mediated thrombocytopenia (IMT). All patients failed to respond to prednisone, which is considered a mainstay of immunosuppressive therapy. Vincristine-loaded platelets (VLPs), which act selectively on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas

Wu HG, Kim IH, Ha SW, Park CI, Bang YJ, Huh DS

The benefits of radio-chemotherapy in HIV-negative primary central nervous system (CNS) lymphomas were analyzed in 40 patients, who received radiotherapy to the brain or craniospinal axis with the total dose...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Chronic myeloid leukemia as a secondary malignancy after diffuse large B-cell lymphoma

Lee HY, Lee KH, Hyun MS, Kim MK, Koh SA, Cho HS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pulmonary Toxicity after a Quick Course of Combinatorial Vincristine, Bleomycin, and Cisplatin Neoadjuvant Chemotherapy in Cervical Cancer

Ki KD, Lee JM, Lee SK, Tong SY, Huh CY, Ryu JK, Kim KY

Pulmonary toxicity is one of the most serious adverse effects associated with a quick course of vincristine, bleomycin, and cisplatin neoadjuvant chemotherapy (NAC-VBP). The aim of this study was to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neural toxicity induced by accidental intrathecal vincristine administration

Kwack EK, Kim DJ, Park TI, Cho KR, Kwon IH, Sohn YK

Described here is a case of accidental intrathecal administration of vincristine with pathologic findings in the central nervous system. A 3-year-old boy with acute lymphoblastic leukemia, was given his ninth...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab

Lim KH, Yoon HI, Kang YA, Lee KW, Kim JH, Bang SM, Lee JH, Lee CT, Lee JS

BACKGROUND/AIMS: The aim of our study was to determine the incidence and clinical features of severe pulmonary complications in patients receiving cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or rituximab plus...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adult T-cell leukemia/lymphoma in a Korean: a case report

Lee SS, Hong SI, Lee DS, Kang YK, Kim CW, Jang JJ

The clinicopathologic features of a Korean patient with adult T-cell leukemia/lymphoma(ATLL) are presented. A 51-year-old man, who has lived in Korea since birth, had multiple cutaneous nodules and multiple lymphadenopathy...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP

Choi YW, Jeong SH, Ahn MS, Lee HW, Kang SY, Choi JH, Jin UR, Park JS

Febrile neutropenia (FN) is the major toxicity of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) regimen in the treatment of diffuse large B-cell lymphoma (DLBCL). The prediction of neutropenia...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Double Autologous Stem Cell Transplantation for Multiple Myeloma: A Korean Single Center Study

Ko OB, Kim S, Shim H, Lee JH, Ahn JM, Yoon SM, Jeon MH, Do IN, Lee SY, Kim YG, Kim SW, Kim SB, Kim SH, Lee JS, Kim W, Park CJ, Chi HS, Suh C

BACKGROUND: Although high dose chemotherapy coupled with an autologous stem cell transplantation (ASCT) is widely accepted as effective therapy for multiple myeloma (MM), few reports are available in Korea, especially...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Mediastinal Single Nodal Relapse of a Nasal Nk/T cell Lymphoma

Rhee KH, Hong SC, An JM, Huh J, Ryu JS, Lee JS, Suh C

A nasal NK/T cell lymphoma is a very aggressive form of lymphoma. Patterns of relapse after treatment have not been systematically evaluated, and mediastinal nodal relapse at a primary site...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-Term Survivals of Stage IIB Osteosarcoma: A 20-Year Experience in a Single Institution

Cho Y, Jung GH, Chung SH, Kim JY, Choi Y, Kim JD

BACKGROUND: The purpose of this study is to evaluate the disease-free survival (DFS) and overall survival (OS) of patients with stage IIB osteosarcoma at a single institution for 20 years...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Modified Number of Extranodal Involved Sites as a Prognosticator in R-CHOP-Treated Patients with Disseminated Diffuse Large B-Cell Lymphoma

Yoo C, Kim S, Sohn BS, Kim JE, Yoon DH, Huh J, Lee DH, Kim SW, Lee JS, Suh C

BACKGROUND/AIMS: Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy (R-CHOP) has improved survival in patients with diffuse large B-cell lymphoma (DLBCL) and weakened the prognostic power of the international prognostic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment Outcomes with CHOP Chemotherapy in Adult Patients with Hemophagocytic Lymphohistiocytosis

Shin HJ, Chung JS, Lee JJ, Sohn SK, Choi YJ, Kim YK, Yang DH, Kim HJ, Kim JG, Joo YD, Lee WS, Sohn CH, Lee EY, Cho GJ

The objective of the current study was to investigate the treatment outcomes for the use of cyclophosphamide, adriamycin, vincristine, and prednisolone (CHOP) chemotherapy in adult patients with hemophagocytic lymphohistiocytosis (HLH)....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical significance of nuclear factor kappaB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy

Shin HC, Seo J, Kang BW, Moon JH, Chae YS, Lee SJ, Lee YJ, Han S, Seo SK, Kim JG, Sohn SK, Park TI

BACKGROUND/AIMS: This study investigated the expression of nuclear factor kappaB (NF-kappaB) and the chemokine receptor (CXCR4) in patients with diffuse large B-cell lymphoma (DLBCL) who received rituximab-based therapy. METHODS: Seventy patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr